As per the research report, the size of the Asia-Pacific Syringes Market has been estimated at USD 2.65 billion in 2021 and is projected to reach USD 4.37 billion by 2026, growing at a CAGR of 10.5% between 2021 to 2026.
Syringes are generally made up of plastic in the form of a cylinder with a piston at one end and a needle at another end. Syringes are used either to inject a drug or take samples of body fluids. Syringes are mainly used for the intake of insulin in diabetes patients.
Some of the factors like a rising aging population, rising Prevalence of Chronic diseases, and technological advancements in Syringe drug delivery are driving the market. The increasing prevalence of Diabetes resulted in a higher demand for syringes. However, factors like the Risk of infection associated with Drug delivery through syringes, high costs of specialized syringes are restraining the market.
This research report on the Asia-Pacific Syringes Market has been segmented and sub-segmented into the following categories:
By Usability:
By Material:
By Type:
By Country:
Based on usability, the disposable syringes segment is expected to command a larger share due to the increasing use of injectable drug delivery, the Rising geriatric population, and the increased risk of infection with reusable syringes.
Geographically, Asia-Pacific is expected to increase at the highest CAGR during the forecast period because of the growing healthcare facilities, technological advancements in developing countries like India and China.
Noteworthy companies leading in the APAC Syringes Market profiled in the report are Becton, Dickinson and Company, Terumo Corporation, Medtronic plc, Smiths Medical, B. Braun Medical Inc., NIPRO Corporation, Hindustan Syringes & Medical Devices Limited, Gerresheimer AG, SCHOTT AG, and CODAN Medizinische Geräte GmbH & Co KG.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Usability
5.1.1 Introduction
5.1.2 Sterilizable/reusable Syringes
5.1.2.1 Hydrodermic Syringes
5.1.2.2 Oral Syringes
5.1.3 Disposable Syringes
5.1.3.1 Conventional
5.1.3.2 safety
5.1.3.2.1 Retractable
5.1.3.2.2 Non-Retractable
5.1.3.3 prefilled
5.1.4 Y-o-Y Growth Analysis, By Usability
5.1.5 Market Attractiveness Analysis, By Usability
5.1.6 Market Share Analysis, By Usability
5.2 Material
5.2.1 Introduction
5.2.2 Glass
5.2.3 Plastic
5.2.4 Y-o-Y Growth Analysis, By Material
5.2.5 Market Attractiveness Analysis, By Material
5.2.6 Market Share Analysis, By Material
5.3 Type
5.3.1 Introduction
5.3.2 General,
5.3.3 Specialized Syringes
5.3.3.1 insulin
5.3.3.2 Tuberculin
5.3.3.3 Allergy
5.3.3.4 Others
5.3.4 Y-o-Y Growth Analysis, By Type
5.3.5 Market Attractiveness Analysis, By Type
5.3.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Usability
6.1.3.3 By Material
6.1.3.4 By Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Usability
6.1.4.3 By Material
6.1.4.4 By Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Usability
6.1.5.3 By Material
6.1.5.4 By Type
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Becton
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 SCHOTT AG
8.3 Terumo Corporation
8.4 Medtronic plc
8.5 Smiths Medical
8.6 B. Braun Medical Inc.
8.7 NIPRO Corporation
8.8 Hindustan Syringes & Medical Devices Limited
8.9 Gerresheimer AG
8.10 CODAN Medizinische Geräte GmbH & Co KG
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
